Skip to main content
. 2021 Jul 3;12(17):5355–5364. doi: 10.7150/jca.60682

Table 4.

Comparisons of line of treatment and best treatment response with mVNR (N=90).

Linage of previous treatments CR, n (%) PR, n (%) SD, n (%) DCR, n (%) PD, n (%) NE, n (%)
≤1, N=59 3(4.9) 30 (56.1) 12 (22.0) 45 (83.0) 12(12.2) 2 (4.9)
≥2, N=31 1(3.2) 14(45.1) 11 (35.5) 26 (83.9) 5 (16.1) 0

CR-complete response; PD-progressive disease; PR-partial response; SD-stable disease; DCR-disease control rate; NE-not evaluable.